Austin, TX – Capital Network Securities (CNS), has announced completion of a second round of financing for San Antonio-based VidaCare Corporation, in the amount of $6.7 million Series B Preferred Stock. The round was led by Telegraph Hill Partners, a San Francisco-based venture capital firm that focuses on investments in medical device companies; it also included several accredited individuals.
VidaCare Corporation owns the exclusive rights to market and sell a patented, innovative medical technology that enables emergency medicine professionals to gain access to the human circulatory system for more than 5 million patients each year that don’t respond to traditional IV needles. This breakthrough could save thousands of lives each year. The device enables Emergency Medical Technicians and Emergency Room physicians to use bone marrow as a non-collapsible vein, through which any drug or fluid can be rapidly and safely administered. Only VidaCare has demonstrated the ability to use a battery powered device to safely penetrate hard adult bones within 10 seconds or less and gain access to the bone marrow.
The VidaCare solution, EZ-IO™, is the first battery powered, FDA-approved product that gives immediate access to the intraosseous space. A small battery-powered device safely penetrates the bone in seconds with a specially designed and patented hollow drill which also functions as a needle for delivery of pharmaceuticals and fluids. For more information about VidaCare Corporation, search www.vidacare.com or use the contact information below.
About Capital Network Securities
Based in Austin, Texas, Capital Network Securities provides equity and debt capital raising services for private and small cap public companies, with a focus on emerging growth companies in the technology, communications, healthcare/life sciences, services, manufacturing, transportation and retail sectors. Placements are made to either accredited individual investors or institutional investors. CNS also offers buy-side and sell-side advisory services for companies and control investors seeking to execute mergers and acquisitions. Its focus is primarily on transaction values between $10 and $100 million. CNS, a wholly-owned subsidiary of CN Group Holdings, LLC, is a member of NASD and of Securities Investor Protection Corporation. More information about CNS may be found at www.cngroupllc.com or the contact information below.